GlassScriptPhysician profile
Titilope Aluko
NPI 1457846081
$775.90
in general payments reported to CMS, 2019-2025
7 companies · $477 in 2025
The $477 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $86.80 · 2024: $212 · 2025: $477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $775.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $229.86 | 2025 | Azur Cx Detachable |
| Inari Medical, INC. | $215.22 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sirtex Medical INC | $182.70 | 2025 | Lava Les (Liquid Embolic System) |
| Balt USA, LLC | $63.69 | 2024-2025 | Prestige Coil System |
| Boston Scientific Corporation | $44.73 | 2024 | Embold Fibered |
| Biogen, INC. | $22.05 | 2025 | Spinraza |
| Siemens Medical Solutions USA, INC. | $17.65 | 2025 | Acuson Origin Diagnostic Ultrasound System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Titilope Aluko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.